Search Results for: insurance

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients

What will we define as a success for any given stem cell biotech like ViaCyte? In academia, even if we do pre-clinical, translational kind of biomedical sciences, we still do not often think about what it takes to succeed in industry. Even if we very much want our research to make a difference for patients, […]

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients Read More »

Not ready for prime time: the three critical challenges for IPS cells

FaviconIPSCELL

If IPS cells are not ready for prime time, it is probably due to these three critical challenges for these amazing cells. TUMORIGENICITY Those of us who work with IPS cells are very excited about their potential for use in regenerative medicine therapies. One serious hurdle we have talked about in the past is tumorigenicity.

Not ready for prime time: the three critical challenges for IPS cells Read More »